SCHEMBL27467166

SCHEMBL27467166

CC(NC(=O)c1ccc(N2CCOCC2)nc1)C(=O)N1CCC2(CC1)CC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
MAPT P10636 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 1/20 0.50
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
STAT3 P40763 1/20 0.46
USP30 Q70CQ3 1/20 0.45
IKBKE Q14164 1/20 0.44
TBK1 Q9UHD2 1/20 0.44
HPGDS O60760 1/20 0.44
PRMT5 O14744 2/20 0.44
FASN P49327 2/20 0.43
KCNQ3 O43525 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27468183 1.00 ALDH1A1 (0.52) ALDH1A1MAPTCYP1A2CYP2C19KDM4E
SCHEMBL27468184 1.00 ALDH1A1 (0.52) ALDH1A1MAPTCYP1A2CYP2C19KDM4E
SCHEMBL27467282 0.90 ALDH1A1 (0.44) ALDH1A1CYP2C19KDM4EPOLBHPGD
SCHEMBL27468375 0.90 ALDH1A1 (0.44) ALDH1A1CYP2C19KDM4EPOLBHPGD
SCHEMBL27468377 0.90 ALDH1A1 (0.44) ALDH1A1CYP2C19KDM4EPOLBHPGD
SCHEMBL27466997 0.83 ITGB3 (0.40) ALDH1A1CYP2C19HPGDHSD17B10SMN1; SMN2
SCHEMBL27467921 0.83 ITGB3 (0.40) ALDH1A1CYP2C19HPGDHSD17B10SMN1; SMN2
SCHEMBL27467918 0.83 ITGB3 (0.40) ALDH1A1CYP2C19HPGDHSD17B10SMN1; SMN2
SCHEMBL27467467 0.82 CYP3A4 (0.40) HSD17B10
SCHEMBL27468603 0.82 CYP3A4 (0.40) HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 WO disclosed